Integrated care in ovarian cancer “IgV Ovar”: results of a German pilot for higher quality in treatment of ovarian cancer

INTRODUCTION: Late-stage ovarian cancer patient’s survival depends on complete cytoreduction and chemotherapy. Complete cytoreduction is more often achieved in institutions with a case volume of >20 cases per year. The Integrated care program Ovar (IgV Ovar) was founded in 2005 and started recrui...

Descripción completa

Detalles Bibliográficos
Autores principales: Keyver-Paik, M.-D., Abramian, A., Domröse, C., Döser, A., Höller, T., Friedrich, M., Meier, W., Menn, K., Kuhn, W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717158/
https://www.ncbi.nlm.nih.gov/pubmed/26498774
http://dx.doi.org/10.1007/s00432-015-2055-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717158/
https://www.ncbi.nlm.nih.gov/pubmed/26498774
http://dx.doi.org/10.1007/s00432-015-2055-6

Ejemplares similares